|
【结 构 式】 
|
【分子编号】43791 【品名】methyl (1R,3R)-1-(1,3-benzodioxol-5-yl)-2-(2-chloroacetyl)-2,3,4,9-tetrahydro-1H-beta-carboline-3-carboxylate 【CA登记号】 |
【 分 子 式 】C22H19ClN2O5 【 分 子 量 】426.85604 【元素组成】C 61.9% H 4.49% Cl 8.31% N 6.56% O 18.74% |
与该中间体有关的原料药合成路线共 3 条
合成路线1
该中间体在本合成路线中的序号：(V)Cyclization of D-tryptophan methyl ester (I) with piperonal (II) by means of TFA in dichloromethane gives, after separation of the undesired trans-isomer by flash chromatography, the (1R,3R-cis)-pyrido-indole derivative (III). The acylation of (III) with chloroacetyl chloride (IV) and NaHCO3 in chloroform yields the chloroacetyl derivative (V), which is finally cyclized with methylamine in methanol.
| 【1】 Daugan, A.; Grondin, P.; Ruault, C.; et al.; The discovery of tadalafil: A novel and highly selective PDE5 inhibitor. 2: 2,3,6,7,12,12a-Hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione analogues. J Med Chem 2003, 46, 21, 4533. |
| 【2】 Martin, L.; Sorbera, L.A.; Leeson, P.A.; Castaner, J.; IC-351. Drugs Fut 2001, 26, 1, 15. |
| 【3】 Daugan, A.C.-M. (Icos Corp.); Tetracyclic derivs., process of preparation and use. EP 0740668; JP 1997508113; US 5859006; US 6025494; US 6127542; WO 9519978 . |
| 【4】 Daugan, A.C.-M. (Icos Corp.); Use of cGMP-phosphodiesterase inhibitors to treat impotence. JP 1999509221; US 6140329; WO 9703675 . |
| 【5】 Gellibert, F.; Daugan, A.C.-M. (Icos Corp.); Tetracyclic cyclic GMP-specific phosphodiesterase inhibitors, process of preparation and use. US 6143746 . |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (I) | 20416 | methyl (2R)-2-amino-3-(1H-indol-3-yl)propanoate | C12H14N2O2 | 详情 | 详情 | |
| (II) | 10127 | 1,3-Benzodioxole-5-carbaldehyde; Heliotropine | 120-57-0 | C8H6O3 | 详情 | 详情 |
| (III) | 43790 | methyl (1R,3R)-1-(1,3-benzodioxol-5-yl)-2,3,4,9-tetrahydro-1H-beta-carboline-3-carboxylate | C20H18N2O4 | 详情 | 详情 | |
| (IV) | 11296 | 2-Chloroacetyl chloride; Chloroacetic chloride | 79-04-9 | C2H2Cl2O | 详情 | 详情 |
| (V) | 43791 | methyl (1R,3R)-1-(1,3-benzodioxol-5-yl)-2-(2-chloroacetyl)-2,3,4,9-tetrahydro-1H-beta-carboline-3-carboxylate | C22H19ClN2O5 | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号：(V)
| 【1】 Jiang WQ, Alford VC, Qiu YH. 2004. Synthesis and SAR of tetracyclic pyrroloquinolones as phosphodies-terase 5 inhibitors. Bioorg Med Chem, 12(6):1505～1515 |
| 【2】 Orme MW, Maninelli MJ, Doecke CW, et aL. 2004. Preparation of tetrahydro-β-carboline diastereomers by modified Pictet-Spengler reaction. W0 2004011463 |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (III) | 10127 | 1,3-Benzodioxole-5-carbaldehyde; Heliotropine | 120-57-0 | C8H6O3 | 详情 | 详情 |
| (I) | 66756 | (R)-2-amino-3-(1H-indol-3-yl)propanoic acid | C11H12N2O2 | 详情 | 详情 | |
| (II) | 66757 | (R)-methyl 2-amino-3-(1H-indol-3-yl)propanoate hydrochloride | C12H14N2O2.HCl | 详情 | 详情 | |
| (IV) | 66758 | methyl (1R,3R)-1-(1,3-benzodioxol-5-yl)-2,3,4,9-tetrahydro-1H-beta-carboline-3-carboxylate hydrochloride | C20H18N2O4.HCl | 详情 | 详情 | |
| (V) | 43791 | methyl (1R,3R)-1-(1,3-benzodioxol-5-yl)-2-(2-chloroacetyl)-2,3,4,9-tetrahydro-1H-beta-carboline-3-carboxylate | C22H19ClN2O5 | 详情 | 详情 |
合成路线3
该中间体在本合成路线中的序号： (II)
| 【1】 Revell JD, Srinivasan N, Ganesan A. 2004. Two concise syntheses of Cialis via the N-acyliminium Pictet-Spengler reaction. Synlett, (8):1428～1430 |
Extended Information